newsfilter
← Latest News
Business Wire·

Merck Completes Tender Offer to Acquire Acceleron Pharma Inc.

Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced the successful completion of the cash tender offer, through a subsidiary, Astros Merger Sub, Inc., for all of the outstanding shares of common stock of Acceleron Pharma